These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 22541243)

  • 1. Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation.
    Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Akashi K; Tanaka Y
    J Allergy Clin Immunol; 2012 Jun; 129(6):1594-601.e2. PubMed ID: 22541243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
    Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
    Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell subsets, signaling and their roles in secretion of autoantibodies.
    Iwata S; Tanaka Y
    Lupus; 2016 Jul; 25(8):850-6. PubMed ID: 27252261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syk is indispensable for CpG-induced activation and differentiation of human B cells.
    Kremlitzka M; Mácsik-Valent B; Erdei A
    Cell Mol Life Sci; 2015 Jun; 72(11):2223-36. PubMed ID: 25543269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
    Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
    Front Immunol; 2019; 10():95. PubMed ID: 30761150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syk mediates BCR- and CD40-signaling integration during B cell activation.
    Ying H; Li Z; Yang L; Zhang J
    Immunobiology; 2011 May; 216(5):566-70. PubMed ID: 21074890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoinhibition and adapter function of Syk.
    Kulathu Y; Grothe G; Reth M
    Immunol Rev; 2009 Nov; 232(1):286-99. PubMed ID: 19909371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK.
    Vendel AC; Calemine-Fenaux J; Izrael-Tomasevic A; Chauhan V; Arnott D; Eaton DL
    J Immunol; 2009 Feb; 182(3):1509-17. PubMed ID: 19155498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus.
    Fleischer SJ; Giesecke C; Mei HE; Lipsky PE; Daridon C; Dörner T
    Arthritis Rheumatol; 2014 Dec; 66(12):3424-35. PubMed ID: 25156507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca(2+) -related signaling events influence TLR9-induced IL-10 secretion in human B cells.
    Ziegler S; Gartner K; Scheuermann U; Zoeller T; Hantzschmann J; Over B; Foermer S; Heeg K; Bekeredjian-Ding I
    Eur J Immunol; 2014 May; 44(5):1285-98. PubMed ID: 24470136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus.
    Iwata S; Yamaoka K; Niiro H; Jabbarzadeh-Tabrizi S; Wang SP; Kondo M; Yoshikawa M; Akashi K; Tanaka Y
    Lupus; 2015 Jun; 24(7):695-704. PubMed ID: 25432781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Involvement of Syk in pathology of systemic autoimmune disease].
    Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Saito K; Akashi K; Tanaka Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(1):56-61. PubMed ID: 22374444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory actions of Syk inhibitors in macrophages involve non-specific inhibition of toll-like receptors-mediated JNK signaling pathway.
    Lin YC; Huang DY; Chu CL; Lin WW
    Mol Immunol; 2010 Apr; 47(7-8):1569-78. PubMed ID: 20138367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation.
    Ozcan E; Rauter I; Garibyan L; Dillon SR; Geha RS
    J Allergy Clin Immunol; 2011 Sep; 128(3):601-9.e1-4. PubMed ID: 21741080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
    Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
    J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunctional BLK in common variable immunodeficiency perturbs B-cell proliferation and ability to elicit antigen-specific CD4+ T-cell help.
    Compeer EB; Janssen W; van Royen-Kerkhof A; van Gijn M; van Montfrans JM; Boes M
    Oncotarget; 2015 May; 6(13):10759-71. PubMed ID: 25926555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.
    He B; Qiao X; Cerutti A
    J Immunol; 2004 Oct; 173(7):4479-91. PubMed ID: 15383579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics.
    Simchoni N; Cunningham-Rundles C
    J Immunol; 2015 Apr; 194(7):3035-44. PubMed ID: 25740945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid-induced IgG production in TLR-activated human primary B cells involves ULK1-mediated autophagy.
    Eriksen AB; Torgersen ML; Holm KL; Abrahamsen G; Spurkland A; Moskaug JØ; Simonsen A; Blomhoff HK
    Autophagy; 2015; 11(3):460-71. PubMed ID: 25749095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD19 controls Toll-like receptor 9 responses in human B cells.
    Morbach H; Schickel JN; Cunningham-Rundles C; Conley ME; Reisli I; Franco JL; Meffre E
    J Allergy Clin Immunol; 2016 Mar; 137(3):889-98.e6. PubMed ID: 26478008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.